WASHINGTON, DC – The Center for Strategic and International Studies (CSIS), a bipartisan, nonprofit policy research organization dedicated to advancing practical ideas to address the world’s greatest ...

Sometimes, one piece of good news is enough to change the mood completely. A delayed train finally arriving. An unexpected message. A long-pending result going your way. Markets work much the same way ...

Shares of companies with major exposure to the US market such as SRF, Navin Fluorine, Acutaas, Neogen Chemicals and Vinati Organics are expected to be in focus on Tuesday, January 3, after the US cut ...

Hyderabad: Chief minister A Revanth Reddy has completed his executive education programme at the Harvard Kennedy School, and was awarded a completion certificate."Chief minister Revanth Reddy and his ...

The Department of Justice is requiring Reddy Ice LLC to divest assets across five states to resolve antitrust concerns from its planned acquisition of an ice maker backed by private equity firm ...

Dr. Reddy's Laboratories (RDY) on Wednesday announced that India’s drug regulator, the Drugs Controller General of India, has issued marketing and manufacturing authorization for a generic version of ...

HYDERABAD, Jan 21 (Reuters) - Indian drugmaker Dr Reddy's (REDY.NS), opens new tab, which reported a smaller-than-expected fall in quarterly profit on Wednesday, said that it has received an approval ...

Beginning in 2026, the ACC's Distinguished Award for International Service will be named in honor of Navin C. Nanda, MD, FACC, thanks to the support of the American Association of Cardiologists of ...

Dr. Reddy’s Laboratories is paying $20 million upfront for the rights to Immutep’s phase 3-stage LAG-3 candidate in certain territories while leaving the Australian biotech with ownership in key ...

What are music’s biggest global artist stories of 2025? Here’s a trio for you: Taylor Swift’s record-shattering The Life Of A Showgirl; Bad Bunny’s culture-defining residency in Puerto Rico (and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min AAR's $78M acquisition of HAECO ...

Dr. Reddy’s Laboratories remains a compelling buy due to underappreciated growth in biosimilars and GLP-1 segments, despite near-term headwinds. RDY's Q2 FY26 results showed modest revenue growth, ...